Return to Emergent BioSolutions

    03.23.2020

    Vaxart + Emergent: In the news

    Original news coverage of Vaxart's agreement with Emergent BioSolutions to manufacture and develop an experimental oral vaccine...

    READ MORE

    03.19.2020

    Vaxart AGREEMENT for Experimental Oral Vaccine Candidate for Coronavirus Disease

    GAITHERSBURG, Md.,March 18, 2020(GLOBE NEWSWIRE) --Emergent BioSolutions Inc.(NYSE:EBS) announced today that it has entered...

    READ MORE
    WANT MORE INFORMATION?

    Learn more about Emergent Bioservices' work and the many milestones we’ve reached in our news release archive below.  If you’re a media representative, please feel free to contact us at cdmo@ebsi.com.

    Interested in learning more about Emergent BioSolutions, Inc.? Please visit emergentbiosolutions.com.

    WANT MORE INFORMATION?

    Learn more about Emergent Bioservices work and the many milestones we’ve reached in our news release archive below.  If you’re a media representative, please feel free to contact us at mediarelations@ebsi.com.

    Interested in learning more about Emergent BioSolutions, Inc.? Please visit emergentbiosolutions.com.